Cancer52 All Member Meeting
The latest Cancer52 All Member Meeting took place on 19 [...]
NHS England unveils new Innovative Medicines Fund
NHS England has launched its new Innovative Medicines Fund (IMF). [...]
First immunotherapy combination of ipilimumab plus nivolumab available to patients in England
We are very pleased to learn that the ipilimumab plus [...]
Flagship cancer fund underspent amid uncertainty over its future
The following article about the underspend by the Cancer Drugs [...]
New Cancer Drugs Fund benefiting thousands of patients and releasing £140m for the NHS
NHS England have released an update on the new Cancer [...]
Majority of recently-approved cancer treatments lack survival benefits
A study published in the British Medical Journal (BMJ) states that two [...]
NHS England spotlight on specialised services – a new report
A new report from NHS England, Spotlight on specialised services, provides [...]
Cancer Drugs Fund driving early access to promising new treatments
The National Institute for Health and Care Excellence (NICE) has [...]
Cancer Drugs Fund has “not delivered meaningful value to patients or society”
A recent study published in the Annals of Oncology and carried [...]
Patients have routine access to more cancer drugs as prices drop, according to NICE
The National Institute for Health and Care Excellence (NICE) reported [...]
